Design, rationale, and baseline demographics of SEARCH I: a prospective cluster-randomized study by Albers F, Shaikh A, Iqbal A

Get full text

Evaluation of potential continuation rules for mepolizumab treatment of severe eosinophilic asthma. by Gunsoy, N, Cockle, S, Yancey, S, Keene, O, Bradford, E, Albers, F, Pavord, I

Biomarkers for severe eosinophilic asthma. by Yancey, S, Keene, O, Albers, F, Ortega, H, Bates, S, Bleecker, E, Pavord, I

Late breaking abstract - Dose-ranging study of mepolizumab in eosinophilic COPD by Pavord, I, Kerstjens, H, Korn, S, Criner, G, Sagara, H, Rubin, D, Harris, S, Mayer, B, Bradford, E, Albers, F, Yancey, S

Mepolizumab for eosinophilic chronic obstructive pulmonary disease by Pavord, I, Chanez, P, Criner, G, Kerstjens, H, Korn, S, Lugogo, N, Martinot, J, Sagara, H, Albers, F, Bradford, E, Harris, S, Mayer, B, Rubin, D, Yancey, S, Sciurba, F

Multinational cohort study of mortality in patients with asthma and severe asthma by Engelkes, M, de Ridder, M, Svensson, E, Berencsi, E, Prieto-Alhambra, D, Lapi, F, Giaquinto, C, Picelli, G, Boudiaf, N, Albers, F, Cockle, S, Bradford, E, Suruki, R, Brusselle, GG, Rijnbeek, P, Sturkenboom, M, Verhamme, K

Multinational, database cohort study to study mortality and risk factors of mortality in patients with asthma by Verhamme, K, Engelkes, M, De Ridder, M, Svensson, E, Berencsi, K, Prieto-Alhambra, D, Lapi, F, Giaquinto, C, Picelli, G, Boudiaf, N, Albers, F, Cockle, S, Bradford, E, Suruki, R, Muellerova, H, Rijnbeek, P, Sturkenboom, M

Incidence and risk factors of pediatric asthma exacerbations in a multinational, multidatabase cohort study by Baan, E, de Ridder, M, Engelkes, M, Svensson, E, Prieto Alhambra, D, Lapi, F, Giaquinto, C, Picelli, G, Albers, F, Evitt, L, Bradford, E, Van Dyke, M, Rijnbeek, P, Sturkenboom, M, Janssens, H, Verhamme, K